Miltenyi University: Cell therapy in autoimmune diseases: from clinical results to patient access

https://www.miltenyibiotec.com/applications/by-research-area/cell-manufacturing-in-clinical-research-settings.html

Sign in to Miltenyi University to view the slides from the video and explore more learning opportunities.
miltenyibiotec.com/university

This educational webinar gives an overview on cell therapy approaches for autoimmune diseases, including an explanation of the mechanism of action of CAR T cells, current clinical outcomes, challenges and solutions for manufacturing of cell therapies in hospitals, and insights on current patient access to advance therapies.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

Видео Miltenyi University: Cell therapy in autoimmune diseases: from clinical results to patient access канала Miltenyi Biotec